• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Innovative Eyewear Inc. Reports First Quarter 2024 Financial Results

    5/14/24 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care
    Get the next $LUCY alert in real time by email

    Units sold increased 150% & Revenue Increased 165% in Q1 2024 vs Q1 2023

    MIAMI, May 14, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW))), a developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the first quarter of 2024.

    Lucyd Glasses
Photo courtesy of Innovative Eyewear Inc.

    Net revenue for the quarter ended March 31, 2024 was $383,471, an increase of 165% from the quarter ended March 31, 2023. This year-over-year increase was primarily attributable to significant volume growth in the e-commerce channel, driven by the Company's strategic advertising and marketing initiatives during the latter portion of 2023 and through the current quarter, combined with recent new product launches (including the Lyte XL and Nautica® Powered by Lucyd collections).

    Future Outlook

    The sales growth reported by the Company precedes the launch of three new product lines - Eddie Bauer® Powered by Lucyd, Reebok® Powered by Lucyd, and the Lucyd Armor smart safety glasses line - all of which we are bullish about as they are expected to present additional revenue generating opportunities for us in 2024. In addition, the Company plans to launch new features for the Lucyd app in 2024, including a paid "Pro" version of the app, which will provide another potential incremental revenue stream for the Company from glasses customers.

    While the Company has started to realize some economies of scale in the cost of frames and in the area of shipping and logistics, the cost of prescription lenses has grown disproportionately and significantly more than the Company's revenue, which has had a significant negative impact on gross profit margin. Prescription smart eyewear offered direct-to-consumer has been a key unique selling point used to attract new customers, bringing an important marketing benefit since it is not offered by most of our competitors. We are working with our current prescription lens provider to explore opportunities to reduce costs and we are also actively in discussions with alternative prescription lens suppliers whom we believe may help further lower our lens fulfillment costs. Ultimately, we believe that the majority of our business will come from frame sales to distributors and eyewear retailers, who will outfit lenses themselves for the final customer. We anticipate that the launches of more co-branded products later this year will help us progress towards our long-term goal of shifting our sales mix over time more towards the wholesale channel, which carries higher margins for us as such sales to our third-party retail store partners do not include the cost of prescription lenses.

    Finally, as we continue to refine our product mix with sales data, we anticipate further reducing our unit costs by focusing only on the highest volume, market-tested styles.

    Harrison Gross, CEO of Innovative Eyewear Inc., commented,

    "Our most recent quarter marked the third sequential quarter of year-over-year revenue growth. I am pleased by our continued growth and excited by the potential of further growth later this year with the upcoming launches of new product lines and upgraded app releases.

    This is an exciting time for the Company. After several years of rigorous R&D and brand development, I believe we are very well-positioned to capitalize on blooming consumer interest in smart eyewear. Recently, we have seen powerful incumbents such as Apple and Meta bringing renewed interest to smart glasses, which helps us quite directly by raising consumer awareness for the category. We believe this has enhanced investor and consumer confidence in the category. As the value leader in prescription smart eyewear, we are a practical alternative to the Apple Vision Pro and Meta Glasses for consumers seeking a lightweight, AI-enabled and affordable option for all-day wear. The fact that our products are available in dozens of different styles, with thousands of frame and custom lens combinations, provides consumers with the necessary optionality that they expect when making an eyewear selection. We continue to expect that smart eyewear will be a key component of the generative AI revolution, due to their transparent interfaces and ergonomic form factors perfectly suited for voice-based interaction."

    Forward Looking Statements

    This press release contains certain forward-looking statements, including those relating to the Company's business operations, projections, market position, future product lines and developments. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "anticipate," "believe," "continue," "estimate," "expect," "future," "intend," "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors."

    Investor Relations Contacts:

    Innovative Eyewear Inc.

    Scott Powell

    Skyline Corporate Communications Group, LLC

    Office: +1 (646) 893-5835

    Email: [email protected]

    Innovative Eyewear (PRNewsfoto/Innovative Eyewear)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-eyewear-inc-reports-first-quarter-2024-financial-results-302144877.html

    SOURCE Innovative Eyewear, Inc.

    Get the next $LUCY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LUCY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LUCY
    SEC Filings

    View All

    Innovative Eyewear Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Innovative Eyewear Inc (0001808377) (Filer)

    8/27/25 7:45:33 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    SEC Form 144 filed by Innovative Eyewear Inc.

    144 - Innovative Eyewear Inc (0001808377) (Subject)

    8/19/25 10:58:12 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Innovative Eyewear Inc (0001808377) (Filer)

    8/15/25 5:01:28 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $LUCY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Innovative Eyewear Inc. Reports Q2 2025 Unaudited Financial Results

    Revenue Surged 88% in Q2 2025 vs. Q2 2024 MIAMI, Aug. 14, 2025 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer®, and Reebok® brands, today announced its unaudited financial results for the three and six months ended June 30, 2025. Net revenue for the quarter ended June 30, 2025 was $579,230, an increase of 88% from the quarter ended June 30, 2024. On a year-to-date basis, net revenue for the six months ended June 30, 2025 was $1,033,731, an increase of 49% from the comparable period in 2024.

    8/14/25 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Announces Participation in Key Industry and Investor Events in Q3 2025

    MIAMI, Aug. 11, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor™, Reebok®, Eddie Bauer® and Nautica® brands, today announces its participation in a series of key investor and industry focused events scheduled throughout the third quarter of 2025. Q3 2025 Scheduled Events Skyline Signature Series Webinar (Virtual; August 12): The Skyline Signature Series is a live virtual webinar that provides public companies with a convenient and effective forum to communicate their story to a diverse audienc

    8/11/25 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Launches Reebok Smartglasses in New Channels

    MIAMI, July 21, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor™, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce that its groundbreaking Reebok athletic smartglasses will be available today on the Reebok mobile app, to be followed by Reebok.com on August 1. The Reebok.com website is a go-to hub for athletic apparel and accessories, receiving approximately 570,000 monthly organic visitors.1 The Company believes this will be a key driver

    7/21/25 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 4:12:34 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 2:41:40 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $2,649,148 worth of shares (297,443 units at $8.91) and sold $384,100 worth of shares (42,328 units at $9.07) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 2:40:55 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gayle Oswald

    3 - Innovative Eyewear Inc (0001808377) (Issuer)

    10/25/24 9:59:55 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 4:12:34 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 2:41:40 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Leadership Updates

    Live Leadership Updates

    View All

    Innovative Eyewear, Inc. Announces Exciting New Features for the Lucyd ChatGPT App

    MIAMI, May 29, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce a powerful new update to the Company's Lucyd app for iOS and Android. The Lucyd app was the first to enable voice access to ChatGPT in smart eyewear, and the Company believes these latest enhancements further advance its market position as a leader in smart eyewear.   Below are the new updates: App Shopping. Both the iOS and

    5/29/25 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear, Inc. Signs Professional Football Player Emmanuel Ogbah as Brand Ambassador

    MIAMI, Dec. 14, 2023 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW))), the developer of the developer of ChatGPT smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce the signing of Emmanuel Ogbah as an official brand ambassador. Emmanuel Ikechukwu Ogbah is a Nigerian professional football defensive end for the Miami Dolphins. He played college football at Oklahoma State and was drafted by the Cleveland Browns in the second round of the 2016 NFL Draft. Lucyd eyewear's open-ear au

    12/14/23 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Financials

    Live finance-specific insights

    View All

    Innovative Eyewear Inc. Reports Third Quarter 2024 Financial Results

    Revenue Increased 14% in Q3 2024 vs Q3 2023, and 76% on a Year-to-Date Basis vs 2023 MIAMI, Nov. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), a developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the third quarter of 2024. Net revenue for the quarter ended September 30, 2024 was $253,599, an increase of 14% from the quarter ended September 30, 2023. This year-over-year increase was primarily attributable to strategic reductions in price discounts and other adjustments to o

    11/13/24 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan

    MIAMI, Sept. 25, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right ("Right") for each outstanding share of common stock. The record date for such dividend distribution is September 25, 2024. The Rights Plan expires, without any further action being required to be taken by Innovative Eyewear's Board of Directors, on September 25, 2025 or at such earlier time as disclos

    9/25/24 8:20:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Inc. Reports Second Quarter 2024 Financial Results

    Quarterly Revenue Increased 82% vs Q2 2023; Gross Margin Increases Substantially MIAMI, Aug. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW))), the developer of ChatGPT-enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the second quarter of 2024. Net revenue for the quarter ended June 30, 2024 was $308,682, an increase of 82% from the quarter ended June 30, 2023. Net revenue for the six months ended June 30, 2024 was $692,153, an increase of 120% vs. the comparable period in 2023.

    8/13/24 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Innovative Eyewear Inc.

    SC 13G/A - Innovative Eyewear Inc (0001808377) (Subject)

    11/13/24 11:18:48 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

    SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

    10/4/24 4:43:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

    SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

    9/25/24 4:17:38 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care